2024-09-012025-08-312025-08-31falseSC383809LOGAN HEALTHCARE LTD2026-05-2986900falseiso4217:GBPxbrli:pureSC3838092024-08-31SC3838092025-08-31SC3838092024-09-012025-08-31SC3838092023-08-31SC3838092024-08-31SC3838092023-09-012024-08-31SC383809bus:SmallEntities2024-09-012025-08-31SC383809bus:AuditExempt-NoAccountantsReport2024-09-012025-08-31SC383809bus:FullAccounts2024-09-012025-08-31SC383809bus:PrivateLimitedCompanyLtd2024-09-012025-08-31SC383809core:WithinOneYear2025-08-31SC383809core:AfterOneYear2025-08-31SC383809core:WithinOneYear2024-08-31SC383809core:AfterOneYear2024-08-31SC383809core:ShareCapital2025-08-31SC383809core:SharePremium2025-08-31SC383809core:RevaluationReserve2025-08-31SC383809core:OtherReservesSubtotal2025-08-31SC383809core:RetainedEarningsAccumulatedLosses2025-08-31SC383809core:ShareCapital2024-08-31SC383809core:SharePremium2024-08-31SC383809core:RevaluationReserve2024-08-31SC383809core:OtherReservesSubtotal2024-08-31SC383809core:RetainedEarningsAccumulatedLosses2024-08-31SC383809core:LandBuildings2025-08-31SC383809core:PlantMachinery2025-08-31SC383809core:Vehicles2025-08-31SC383809core:FurnitureFittings2025-08-31SC383809core:OfficeEquipment2025-08-31SC383809core:NetGoodwill2025-08-31SC383809core:IntangibleAssetsOtherThanGoodwill2025-08-31SC383809core:ListedExchangeTraded2025-08-31SC383809core:UnlistedNon-exchangeTraded2025-08-31SC383809core:LandBuildings2024-08-31SC383809core:PlantMachinery2024-08-31SC383809core:Vehicles2024-08-31SC383809core:FurnitureFittings2024-08-31SC383809core:OfficeEquipment2024-08-31SC383809core:NetGoodwill2024-08-31SC383809core:IntangibleAssetsOtherThanGoodwill2024-08-31SC383809core:ListedExchangeTraded2024-08-31SC383809core:UnlistedNon-exchangeTraded2024-08-31SC383809core:LandBuildings2024-09-012025-08-31SC383809core:PlantMachinery2024-09-012025-08-31SC383809core:Vehicles2024-09-012025-08-31SC383809core:FurnitureFittings2024-09-012025-08-31SC383809core:OfficeEquipment2024-09-012025-08-31SC383809core:NetGoodwill2024-09-012025-08-31SC383809core:IntangibleAssetsOtherThanGoodwill2024-09-012025-08-31SC383809core:ListedExchangeTraded2024-09-012025-08-31SC383809core:UnlistedNon-exchangeTraded2024-09-012025-08-31SC383809core:MoreThanFiveYears2024-09-012025-08-31SC383809core:Non-currentFinancialInstruments2025-08-31SC383809core:Non-currentFinancialInstruments2024-08-31SC383809dpl:CostSales2024-09-012025-08-31SC383809dpl:DistributionCosts2024-09-012025-08-31SC383809core:LandBuildings2024-09-012025-08-31SC383809core:PlantMachinery2024-09-012025-08-31SC383809core:Vehicles2024-09-012025-08-31SC383809core:FurnitureFittings2024-09-012025-08-31SC383809core:OfficeEquipment2024-09-012025-08-31SC383809dpl:AdministrativeExpenses2024-09-012025-08-31SC383809core:NetGoodwill2024-09-012025-08-31SC383809core:IntangibleAssetsOtherThanGoodwill2024-09-012025-08-31SC383809dpl:GroupUndertakings2024-09-012025-08-31SC383809dpl:ParticipatingInterests2024-09-012025-08-31SC383809dpl:GroupUndertakingscore:ListedExchangeTraded2024-09-012025-08-31SC383809core:ListedExchangeTraded2024-09-012025-08-31SC383809dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-09-012025-08-31SC383809core:UnlistedNon-exchangeTraded2024-09-012025-08-31SC383809dpl:CostSales2023-09-012024-08-31SC383809dpl:DistributionCosts2023-09-012024-08-31SC383809core:LandBuildings2023-09-012024-08-31SC383809core:PlantMachinery2023-09-012024-08-31SC383809core:Vehicles2023-09-012024-08-31SC383809core:FurnitureFittings2023-09-012024-08-31SC383809core:OfficeEquipment2023-09-012024-08-31SC383809dpl:AdministrativeExpenses2023-09-012024-08-31SC383809core:NetGoodwill2023-09-012024-08-31SC383809core:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-31SC383809dpl:GroupUndertakings2023-09-012024-08-31SC383809dpl:ParticipatingInterests2023-09-012024-08-31SC383809dpl:GroupUndertakingscore:ListedExchangeTraded2023-09-012024-08-31SC383809core:ListedExchangeTraded2023-09-012024-08-31SC383809dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-09-012024-08-31SC383809core:UnlistedNon-exchangeTraded2023-09-012024-08-31SC383809core:NetGoodwill2025-08-31SC383809core:IntangibleAssetsOtherThanGoodwill2025-08-31SC383809core:LandBuildings2025-08-31SC383809core:PlantMachinery2025-08-31SC383809core:Vehicles2025-08-31SC383809core:FurnitureFittings2025-08-31SC383809core:OfficeEquipment2025-08-31SC383809core:AfterOneYear2025-08-31SC383809core:WithinOneYear2025-08-31SC383809core:ListedExchangeTraded2025-08-31SC383809core:UnlistedNon-exchangeTraded2025-08-31SC383809core:ShareCapital2025-08-31SC383809core:SharePremium2025-08-31SC383809core:RevaluationReserve2025-08-31SC383809core:OtherReservesSubtotal2025-08-31SC383809core:RetainedEarningsAccumulatedLosses2025-08-31SC383809core:NetGoodwill2024-08-31SC383809core:IntangibleAssetsOtherThanGoodwill2024-08-31SC383809core:LandBuildings2024-08-31SC383809core:PlantMachinery2024-08-31SC383809core:Vehicles2024-08-31SC383809core:FurnitureFittings2024-08-31SC383809core:OfficeEquipment2024-08-31SC383809core:AfterOneYear2024-08-31SC383809core:WithinOneYear2024-08-31SC383809core:ListedExchangeTraded2024-08-31SC383809core:UnlistedNon-exchangeTraded2024-08-31SC383809core:ShareCapital2024-08-31SC383809core:SharePremium2024-08-31SC383809core:RevaluationReserve2024-08-31SC383809core:OtherReservesSubtotal2024-08-31SC383809core:RetainedEarningsAccumulatedLosses2024-08-31SC383809core:NetGoodwill2023-08-31SC383809core:IntangibleAssetsOtherThanGoodwill2023-08-31SC383809core:LandBuildings2023-08-31SC383809core:PlantMachinery2023-08-31SC383809core:Vehicles2023-08-31SC383809core:FurnitureFittings2023-08-31SC383809core:OfficeEquipment2023-08-31SC383809core:AfterOneYear2023-08-31SC383809core:WithinOneYear2023-08-31SC383809core:ListedExchangeTraded2023-08-31SC383809core:UnlistedNon-exchangeTraded2023-08-31SC383809core:ShareCapital2023-08-31SC383809core:SharePremium2023-08-31SC383809core:RevaluationReserve2023-08-31SC383809core:OtherReservesSubtotal2023-08-31SC383809core:RetainedEarningsAccumulatedLosses2023-08-31SC383809core:AfterOneYear2024-09-012025-08-31SC383809core:WithinOneYear2024-09-012025-08-31SC383809core:Non-currentFinancialInstrumentscore:CostValuation2024-09-012025-08-31SC383809core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-012025-08-31SC383809core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-012025-08-31SC383809core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-012025-08-31SC383809core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-012025-08-31SC383809core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-012025-08-31SC383809core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-012025-08-31SC383809core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-012025-08-31SC383809core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-012025-08-31SC383809core:Non-currentFinancialInstrumentscore:CostValuation2025-08-31SC383809core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-08-31SC383809core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-08-31SC383809core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-08-31SC383809core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-08-31SC383809core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-08-31SC383809core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-08-31SC383809core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-08-31SC383809core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-08-31SC383809core:Non-currentFinancialInstrumentscore:CostValuation2024-08-31SC383809core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-08-31SC383809core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-08-31SC383809core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-08-31SC383809core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-08-31SC383809core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-08-31SC383809core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-08-31SC383809core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-08-31SC383809core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-08-31SC383809bus:Director12024-09-012025-08-31SC383809core:FurnitureFittingsToolsEquipment2024-08-31SC383809core:FurnitureFittingsToolsEquipment2024-09-012025-08-31SC383809core:FurnitureFittingsToolsEquipment2025-08-31

LOGAN HEALTHCARE LTD

Registered Number
SC383809
(Scotland)

Unaudited Financial Statements for the Year ended
31 August 2025

LOGAN HEALTHCARE LTD
Company Information
for the year from 1 September 2024 to 31 August 2025

Director

A Mohammed

Registered Address

77 Dunn Street
Glasgow
G40 3PA

Registered Number

SC383809 (Scotland)
LOGAN HEALTHCARE LTD
Balance Sheet as at
31 August 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets3615,933694,562
Tangible assets41,334,5241,077,000
1,950,4571,771,562
Current assets
Stocks5206,109159,500
Debtors61,000,363861,645
Cash at bank and on hand301,637440,028
1,508,1091,461,173
Creditors amounts falling due within one year7(2,226,899)(2,055,649)
Net current assets (liabilities)(718,790)(594,476)
Total assets less current liabilities1,231,6671,177,086
Net assets1,231,6671,177,086
Capital and reserves
Called up share capital1010
Other reserves400,000400,000
Profit and loss account831,657777,076
Shareholders' funds1,231,6671,177,086
The financial statements were approved and authorised for issue by the Director on 29 May 2026, and are signed on its behalf by:
A Mohammed
Director
Registered Company No. SC383809
LOGAN HEALTHCARE LTD
Notes to the Financial Statements
for the year ended 31 August 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
2.Average number of employees

20252024
Average number of employees during the year3941
3.Intangible assets

Goodwill

Total

££
Cost or valuation
At 01 September 241,761,2971,761,297
At 31 August 251,761,2971,761,297
Amortisation and impairment
At 01 September 241,066,7351,066,735
Charge for year78,62978,629
At 31 August 251,145,3641,145,364
Net book value
At 31 August 25615,933615,933
At 31 August 24694,562694,562
4.Tangible fixed assets

Land & buildings

Plant & machinery

Vehicles

Fixtures & fittings

Office Equipment

Total

££££££
Cost or valuation
At 01 September 24945,07610,994133,662184,3946,4281,280,554
Additions51,168181,75597,0896,1051,851337,968
At 31 August 25996,244192,749230,751190,4998,2791,618,522
Depreciation and impairment
At 01 September 24-10,719103,54685,0534,236203,554
Charge for year-39,80219,29720,40693980,444
At 31 August 25-50,521122,843105,4595,175283,998
Net book value
At 31 August 25996,244142,228107,90885,0403,1041,334,524
At 31 August 24945,07627530,11699,3412,1921,077,000
5.Stocks

2025

2024

££
Other stocks206,109159,500
Total206,109159,500
6.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables782,283666,008
Amounts owed by group undertakings48,36467,494
Other debtors169,716124,285
Prepayments and accrued income-3,858
Total1,000,363861,645
7.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables598,241860,806
Taxation and social security23,441139,500
Redeemable preference shares, liability575,000575,000
Other creditors1,026,617476,744
Accrued liabilities and deferred income3,6003,599
Total2,226,8992,055,649
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
8.Directors advances, credits and guarantees
Other debtors include, Director loan account balance of NIL (2024- £Nil).
9.Related party transactions
Amounts owed by group undertakings of £48,364 (2024: £67,642) relates to Logan Pharmaceuticals Limited. This is a wholly owned subsidiary of the Parent company Logan Holdings Company Limited and debtors includes balance of £86,367 related to Logan Holdings Company Limited. Other creditors includes balance of £1,004,068 (2024: 453,630) relates to AFM Investments Limited.